欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/V/0386/001
药品名称Telmitraxx 4 mg/ml oral solution for cats
活性成分
    • telmisartan 4.0 mg/ml
剂型Oral solution
上市许可持有人Alfasan Nederland B.V. Kuipersweg 9, 3449 JA The Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Czechia (CZ)
    • Portugal (PT)
    • Cyprus (CY)
    • Spain (ES)
    • Bulgaria (BG)
    • France (FR)
    • Hungary (HU)
    • Austria (AT)
    • Estonia (EE)
    • Ireland (IE)
    • Lithuania (LT)
    • Iceland (IS)
    • Latvia (LV)
    • Luxembourg (LU)
    • Poland (PL)
    • United Kingdom (Northern Ireland) (XI)
    • Belgium (BE)
      Telmitraxx 4 mg/ml
    • Finland (FI)
    • Denmark (DK)
    • Norway (NO)
    • Slovenia (SI)
    • Germany (DE)
    • Sweden (SE)
    • Slovakia (SK)
    • Greece (GR)
    • Romania (RO)
    • Italy (IT)
    • Croatia (HR)
许可日期2023/05/31
最近更新日期2023/10/13
药物ATC编码
    • QC09CA07 telmisartan
申请类型
  • TypeLevel1：non-food
  • TypeLevel2：Pharmaceutical
  • TypeLevel3：Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase